Biotechnology

The Hurley Group has transformed an existing office building in New Haven to create the Elm City Bioscience Center. Designed by Svigals + Partners, the adaptive reuse project offers over 100,000 sf of leasable research space for startup companies. Featuring BSL-1 and BSL-2 environments, the eight-story biotech hub provides lab suites with adjacent work areas, meeting rooms, and break rooms. Advanced mechanical, electrical, and plumbing systems enable the structure’s 12,000-sf floor plates to easily adapt to changing requirements and configurations.

Mispro Biotech Services is building a 10,000-sf contract vivarium in Boston's Seaport District. The state-of-the-art facility will enable life science companies of all sizes to conduct preclinical drug development studies on rodents with the support of Mispro’s husbandry services, technical expertise, and regulatory compliance oversight.

The United States Congress passed Senate Bill 5002 in late 2022 to allow methods other than animal testing to be employed to establish drug efficacy and safety. Dubbed the FDA Modernization Act 2.0, the legislation supports the inclusion of cell-based assays, computer models, and microphysiological systems such as organ chips in preclinical testing operations. The bill also rescinds a stipulation that animal studies must be used when seeking a license for a biological product that is biosimilar or interchangeable with another product.

Cal State East Bay broke ground in December of 2022 on the $30 million Applied Sciences Center in Hayward, Calif. Designed by SmithGroup, the 22,165-sf facility will provide flexible classrooms for active learning, a technology innovation hub, and interdisciplinary research space for programs in computer science and engineering. Open-concept laboratories will allow multiple student and faculty teams to engage in collaborative discovery.

Lincoln Property Company and FCP are constructing the Colorado Research Exchange (CoRE) in Broomfield to provide leading-edge lab and office environments for biomedical, pharmaceutical, and technology companies. Designed by HKS Architects, the 461,500-rsf complex will include three structures ranging from 114,000 sf to 173,000 sf. Supported by advanced HVAC systems and emergency backup generators, this innovation ecosystem will offer leasable floor plates of up to 40,000 sf with ceiling heights between 14 and 18 feet.

The Centre for Process Innovation (CPI) opened the Medicines Manufacturing Innovation Centre in December of 2022 in Inchinnan in the United Kingdom. Situated in the heart of the Advanced Manufacturing Innovation District Scotland, the £88 million facility features sophisticated GMP environments where new pharmaceutical production methods can be proven at scale.

Thor Equities opened a 350,000-sf research facility in Jersey City in October of 2022. Designed by SGA, the adaptive reuse project transformed a former toothpaste factory into a vibrant R&D center offering leasable lab and office environments. Featuring a selection of suites with infrastructure, casework, and equipment already installed, the eight-story structure integrates flexible floor plates, multiple utility grids, an onsite life safety generator, and 125 underground parking spaces.

King Street Properties broke ground in October of 2022 on the $915 million Allston LabWorks complex in Boston. Designed by DiMella Shaffer, the vibrant life sciences campus will provide 534,000 sf of leading-edge lab and office space across two research buildings. Standing six and eight stories high, the highly efficient structures will feature generous floor-to-floor heights to accommodate sophisticated instrumentation.

Amgen opened a 245,000-sf R&D center in South San Francisco in October of 2022. Located on the Gateway of Pacific life sciences campus in Oyster Point, the leased facility was designed by Flad Architects and developed by BioMed Realty. Featuring modular wet and molecular labs, the nine-story tower accommodates Amgen's research programs in oncology, inflammation, and cardiometabolic diseases. Flexible floor plates integrate lab and office functions, with open work spaces and movable furnishings promoting collaboration and interaction.

Johnson & Johnson opened its San Francisco Bay Campus in September of 2022 in Brisbane, Calif. Accommodating up to 400 employees, the 200,000-sf facility bridges key scientific and technological capabilities by collocating the biomedical research activities of subsidiary firm Janssen Pharmaceuticals with J&J's innovation and technology divisions. The collaborative R&D hub houses leading-edge laboratories, flexible office environments, and space for joint development with industry partners.

CSL completed construction in September of 2022 on its $150 million R&D campus in Marburg, Germany. Located in the Görzhausen Industrial Park, the 430,000-sf facility offers sophisticated environments for the creation of next-generation mRNA vaccines, recombinant technologies, and cell and gene therapies. Accommodating up to 500 employees, the multidisciplinary complex represents CSL’s largest global research hub with 75,000 sf of lab space and 75,000 sf of office space.

Sartorius is constructing the $60 million Center of Excellence for BioAnalytics in Ann Arbor, Mich. Designed by Hobbs+Black Architects, the 130,000-sf building will include a process development lab to accelerate the creation of advanced medical therapies. Providing next-generation facilities for biopharmaceutical research, development, production, and testing, the project will enable the company to consolidate business operations currently dispersed throughout Washtenaw County and beyond.

Thermo Fisher Scientific opened a 300,000-sf viral vector center in August of 2022 in Plainville, Mass. Accelerating the creation of advanced cell and gene therapies, the cGMP-compliant facility offers flexible laboratories and production suites for the development, testing, and manufacture of viral vectors. Featuring Thermo Fisher’s advanced bioprocessing technologies and analytical instrumentation, the sustainably designed structure also includes sophisticated office environments and adjacent warehouse spaces.

Pfizer is expanding its Chesterfield campus with the construction of a $60 million addition to support vaccine research and development. Providing leading-edge labs, offices, and support spaces, the three-story, 37,000-sf project will adjoin an existing 261,000-sf facility that opened in 2019. A two-story bridge with a covered plaza will link the completed structure to the rest of the 31-acre site. 

Breakthrough Properties began construction in August of 2022 on the One Canal life sciences center in Cambridge, Mass. Designed to accommodate either a single tenant or multiple companies, the project involves the renovation of an existing structure to provide 105,000 sf of best-in-class biomedical research space. Occupants will enjoy private outdoor meeting venues, integrated retail amenities, and a fitness center.